Oseltamivir (Tamiflu) Renal Dose Adjustments
For adults with creatinine clearance 10–30 mL/min, reduce the treatment dose to 75 mg once daily for 5 days and the prophylaxis dose to 75 mg every other day for 10 days (5 total doses); alternatively, 30 mg once daily may be used for prophylaxis. 1, 2, 3
Critical Threshold for Dose Adjustment
- The key threshold requiring oseltamivir dose reduction is creatinine clearance <30 mL/min, not age or other factors. 1, 2
- Oseltamivir carboxylate (the active metabolite) is eliminated >99% by renal excretion, and serum concentrations increase 2–3 fold in patients with CrCl 10–30 mL/min compared to those with normal renal function. 2
- No dose adjustment is required based on age alone, even in patients ≥65 years with normal renal function. 4, 1
Standard Dosing (CrCl >30 mL/min)
- Treatment: 75 mg orally twice daily for 5 days. 1, 5, 3
- Prophylaxis: 75 mg orally once daily for 10 days (post-exposure) or up to 6 weeks (community outbreak). 1, 2, 3
Moderate Renal Impairment (CrCl 10–30 mL/min)
- Treatment: 75 mg orally once daily for 5 days (instead of twice daily). 4, 1, 2, 3
- Prophylaxis: 75 mg orally every other day for 10 days (5 total doses). 4, 1, 2, 3
Severe Renal Impairment (CrCl <10 mL/min)
Hemodialysis Patients
- Treatment: 30 mg immediately, then 30 mg after each hemodialysis session (maximum 5 days). 1, 2, 3
- Prophylaxis: 30 mg immediately, then 30 mg after every alternate hemodialysis session. 1, 2, 3
Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Treatment: Single 30 mg dose administered immediately. 3
- Prophylaxis: 30 mg immediately, then 30 mg once weekly. 3
End-Stage Renal Disease NOT on Dialysis
Alternative: Zanamivir for Renal Impairment
- Zanamivir (inhaled) requires no dose adjustment for any degree of renal impairment, including end-stage renal disease, making it an excellent alternative for patients with severe renal dysfunction. 4, 2
- Dosing: 10 mg (two inhalations) twice daily for treatment or once daily for prophylaxis, regardless of renal function. 4, 2
- Caution: Zanamivir is contraindicated in patients with underlying airway disease (asthma, COPD) due to bronchospasm risk. 4
Renal Dosing Summary Table
| Creatinine Clearance | Treatment Dose | Prophylaxis Dose |
|---|---|---|
| >60 mL/min | 75 mg twice daily × 5 days | 75 mg once daily × 10 days |
| 30–60 mL/min | 30 mg twice daily × 5 days | 30 mg once daily × 10 days |
| 10–30 mL/min | 75 mg once daily × 5 days OR 30 mg once daily × 5 days | 75 mg every other day × 10 days (5 doses) OR 30 mg once daily × 10 days |
| <10 mL/min on hemodialysis | 30 mg immediately, then 30 mg after each dialysis (max 5 days) | 30 mg immediately, then 30 mg after alternate dialysis sessions |
| <10 mL/min on CAPD | 30 mg single dose | 30 mg immediately, then 30 mg weekly |
| <10 mL/min NOT on dialysis | NOT recommended | NOT recommended |
Common Pitfalls to Avoid
- Do not use standard dosing in patients with CrCl <30 mL/min—this leads to drug accumulation and increased toxicity risk. 2
- Do not confuse treatment dosing (twice daily) with prophylaxis dosing (once daily)—this is a common error even before renal adjustment. 5
- Do not forget to adjust for moderate impairment (CrCl 30–60 mL/min)—many clinicians only adjust for severe impairment. 3
- Measure creatinine clearance, not just serum creatinine—elderly patients may have normal creatinine but significantly reduced clearance. 2
Administration Considerations
- Taking oseltamivir with food significantly reduces nausea and vomiting (occurring in ~10–15% of patients), without affecting antiviral efficacy. 1, 5, 6
- The oral suspension (6 mg/mL) can be used for patients unable to swallow capsules; capsules may also be opened and mixed with sweetened liquid. 1, 3